Original Research
Published on 02 Feb 2026
Hydroxysafflor yellow A attenuates sepsis-induced intestinal barrier dysfunction by modulating Bcl-2/SOD2-mediated mitochondrial apoptosis
in Inflammation Pharmacology
- 490 views
Original Research
Published on 02 Feb 2026
in Inflammation Pharmacology
Editorial
Published on 02 Feb 2026
in Ethnopharmacology
Original Research
Published on 02 Feb 2026
in Cardiovascular and Smooth Muscle Pharmacology
Mini Review
Published on 02 Feb 2026
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 02 Feb 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 02 Feb 2026
in Experimental Pharmacology and Drug Discovery
Review
Published on 02 Feb 2026
in Neuropharmacology
Original Research
Published on 02 Feb 2026
in Drug Metabolism and Transport
Review
Accepted on 31 Jan 2026
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 31 Jan 2026
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 30 Jan 2026
in Neuropharmacology
Original Research
Accepted on 30 Jan 2026
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 30 Jan 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 30 Jan 2026
in Experimental Pharmacology and Drug Discovery
Mini Review
Accepted on 30 Jan 2026
in Ethnopharmacology
Review
Accepted on 30 Jan 2026
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 30 Jan 2026
in Pharmacoepidemiology
Original Research
Accepted on 30 Jan 2026
in Pharmacoepidemiology
Original Research
Accepted on 30 Jan 2026
in Drugs Outcomes Research and Policies
Original Research
Accepted on 30 Jan 2026
in Drugs Outcomes Research and Policies
Review
Accepted on 30 Jan 2026
in Pharmacoepidemiology
Review
Accepted on 30 Jan 2026
in Inflammation Pharmacology
Original Research
Accepted on 30 Jan 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 30 Jan 2026
in Experimental Pharmacology and Drug Discovery